Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.

Por Jörg Schüpbach, Christoph Niederhauser, Sabine Yerly, Stephan Regenass, Meri Gorgievski, Vincent Aubert, Diana Ciardo, Thomas Klimkait, Günter Dollenmaier, Corinne Andreutti, Gladys Martinetti, Marcel Brandenberger, Martin D Gebhardt
Publicado em 2015-01-01

Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.

Por Denise Kühnert, Roger Kouyos, George Shirreff, Jūlija Pečerska, Alexandra U Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Huldrych F Günthard, Tanja Stadler, Sebastian Bonhoeffer, Swiss HIV Cohort Study
Publicado em 2018-02-01

Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds.

Por Wan-Lin Yang, Roger D Kouyos, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Alexandra U Scherrer, Mohaned Shilaih, Trevor Hinkley, Christos Petropoulos, Sebastian Bonhoeffer, Huldrych F Günthard, Swiss HIV Cohort Study (SHCS)
Publicado em 2015-03-01

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.

Por Alexandra U Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F Günthard, Swiss HIV Cohort Study (SHCS)
Publicado em 2012-01-01